Search results
Results from the Tech24 Deals Content Network
Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV), also known as Ebola Zaire vaccine live and sold under the brand name Ervebo, is an Ebola vaccine for adults that prevents Ebola caused by the Zaire ebolavirus. When used in ring vaccination, rVSV-ZEBOV has shown a high level of protection.
Kraft Heinz CEO Carlos Abrams-Rivera eats just two meals a day, between 11 a.m. and 7 p.m., as part of his intermittent-fasting routine.
Moderna, Inc. Moderna, Inc. ( / məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.
The Kraft Heinz Company ( KHC ), commonly known as Kraft Heinz ( / ˈkræft ˈhaɪnz / ), is an American multinational food company formed by the merger of Kraft Foods and H.J. Heinz Company co-headquartered in Chicago and Pittsburgh. [4] [5] Kraft Heinz is the third-largest food and beverage company in North America and the fifth-largest in ...
CHICAGO -- Packaged foods giant Kraft Heinz said Carlos Abrams-Rivera, the company’s executive vice president and president of its North American business, will take over as chief executive Jan. 1.
Kraft Heinz Co's incoming chief executive, Miguel Patricio, is indicating a change in strategy for the packaged food company that could move it away from the aggressive cost-focused culture that ...
He is a member of G100, a private group of chief executives from the world's largest companies. [2] In December 2014 John Cahill was named CEO of Kraft foods. [6] In March 2015, it was announced that Kraft Foods would merge with Heinz to form Kraft Heinz. Cahill became vice chairman of the new merged company.
July 9, 2024 at 9:17 AM. (Reuters) -Pfizer said on Tuesday Chief Scientific Officer Mikael Dolsten, a key figure behind the development of its COVID-19 vaccine, would step down after a more than ...